Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Sarcoma 2Osteosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Lymphoma 1Leukemia 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × trimetrexate glucuronate × Clear all
NCT00002955 2014-05-22

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas

University of Southern California

Phase 2 Completed
21 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00003776 2013-06-21

Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Sarcoma

Sarcoma, Osteosarcoma

NCT00002738 2013-03-07

Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
25 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Sarcoma, Osteosarcoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡